$SVA made a good perfo in 2015 and for me this is a buy. Next target is 0.319 again and 215 high 0.4$. My extensions are on 0.54 and 0.635$.
Bellus Health got a massive gap which droves the the company back into the penniestock level May this year. Still no buyers interests appear for KIACTA™. But as we saw yesterday on Navidea prices there're more examples on the market which show Investors the opposite hidden interests in good studies to buy for producing.
Microbix is near on it's alltime lows, the website is offline but last news I found was a growth net income per share $0.001 in Q3. Worth watching it
just wow, to be hinest the perfo of this yesterday I didn' expect ! I launched this stock long time ago and it happened absolutely nothing. As always you can't expect a pennie breakes out at least or would be overtaken and supplies a rally like this.... So here I would be careful even if the move was driven by fundamental sale of Lymphoseek to Cardinal Health it...
Stemcells Inc. has beaten all my expectations. Since merging with Microbot there is a lot of cashflow running in. Investors of Microbot hold up to 75% in longer perspective so this picking still slides hihgly potential to be the next Gilead. Next target would proceed the incompleted gap close from May while it rumoured the company puts all operations. This shows...
GO HSORT GUYS WITH LEAP OPTIONS OF NEEDED. PFIZER TOPPED OUT. buy the rumor sell the news " Pfizer to Buy Medivation for $14 Billion" The bigger the buy the greater the fall. www.wsj.com PFIZER is trying her last bet to survive but eventually will fall. wish Pfizer CEO and all the board directors can see it for them to look for new job or polish up resume or...
Looking for places to invest your money in light of cheap oil prises? Probably it is a high time the other way around. Companies (such as Aemetis) involved in biochemistry and renewable operations are picking up steam to replace often overpriced oil giants. Technical analysis implies the same thing as Aemetis, Inc. touched it 2009 low and ready to jump up any...
RECENTLY most of the biotech companies are doing bad but somehow this ETF is going up. I saw weakness in technical analysis of monthly charts but weekly and daily needs to go down before shorting. Think this IBB bull will be ashort lived and once broken it will be a free fall zone. Leap options for short side will be a good bet. Don't go short yet but a good...
Either going to bounve, or brake nasty... I think it's going to bounce and then die. Look for neg divergences to short later...
Biotech bubble has burst. Every rallies are to be sold, and despite the euphoria/new highs in S&P and Nasdaq have barely registered a decent retracement in the biotech sector.. Here's a larger picture of how far biotechs have went since 2008: The uptrend in S&P is limited, and it will only be a matter of time before it collapses off this rising wedge....
Seems like a nice short here with SL above daily high: - Ascending Wedge break + pullback - Divergence on the Sto - On higher timeframes it is bearish